Diabetic Foot Ulcers (DFUs)
9
4
4
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (9)
Phase 2a Dose Finding Study of Nu-3 Gel in Subjects With Mild iDFU
A Study on the Efficacy and Safety of a Nitric Oxide Generating Dressing in the Treatment of Diabetes Related Foot Ulcers.
Study of Miro3D Wound Matrix for Healing Wounds and Ulcers in Outpatient Care
Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound Healing
Efficacy of Carbonlife Amniotic Tissue Product in the Treatment of Chronic Wounds
Evaluation of the Clinical Efficacy and Feasibility of Digital Foot Care Intervention Strategies With Different Intensities in the Prevention of Diabetic Foot Ulcers.
A Real-World Registry of Chronic Wounds and Ulcers
Clinical Trial Evaluating an Amnion Membrane Allograft for Use in the Management of Non- Healing Diabetic Foot Ulcers Versus Standard Of Care
Effect of Meso Wound Matrix in the Treatment of DFUs